Aspirin for Dukes C and High Risk Dukes B Colorectal Cancers - An International, Multi-Center, Double Blind, Randomized Placebo Controlled Phase III Trial.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Aspirin (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- Acronyms ASCOLT
- 13 Sep 2021 Biomarkers information updated
- 18 Sep 2013 Planned number of patients changed from 2660 to 1200 as reported by ClinicalTrials.gov.
- 23 Jul 2013 Planned end date changed from 1 Dec 2020 to 1 Jun 2021 as reported by ClinicalTrials.gov.